Back
Apogee Therapeutics Stock Price Chart
The dark truth about AI
Click here to learn more...
Sell
38
APGE
Apogee Therapeutics
Last Price:
44.51
Seasonality Move:
208.29%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APGE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Apogee Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.02 | Sell |
| 20-day SMA: | 46.24 | Sell |
| 50-day SMA: | 51.62 | Sell |
| 200-day SMA: | 50.76 | Sell |
| 8-day EMA: | 46.75 | Sell |
| 20-day EMA: | 47.87 | Sell |
| 50-day EMA: | 49.88 | Sell |
| 200-day EMA: | 45.93 | Sell |
Apogee Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.39 | Sell |
| Relative Strength Index (14 RSI): | 41.05 | Sell |
| Chaikin Money Flow: | 362169 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.33 - 53.25) | Sell |
| Bollinger Bands (100): | (45.37 - 55.77) | Sell |
Apogee Therapeutics Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apogee Therapeutics Stock
Is Apogee Therapeutics Stock a Buy?
- Apogee Therapeutics share price is 44.50 while APGE 8-day simple moving average is 48.02, which is a Sell signal.
- The stock price of APGE is 44.50 while Apogee Therapeutics 20-day SMA is 46.24, which makes it a Sell.
- Apogee Therapeutics 50-day simple moving average is 51.62 while APGE share price is 44.50, making it a Sell technically.
- APGE stock price is 44.50 and Apogee Therapeutics 200-day simple moving average is 50.76, creating a Sell signal.
APGE Technical Analysis vs Fundamental Analysis
Sell
38
Apogee Therapeutics (APGE)
is a Sell
Is Apogee Therapeutics a Buy or a Sell?
-
Apogee Therapeutics stock is rated a Sell
The current Apogee Therapeutics [APGE] share price is $44.50. The Score for APGE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Apogee Therapeutics Stock Info
Market Cap:
2.53B
Price in USD:
44.50
Share Volume:
686.74K
Apogee Therapeutics 52-Week Range
52-Week High:
72.29
52-Week Low:
22.11
Sell
38
Apogee Therapeutics (APGE)
is a Sell
Apogee Therapeutics Share Price Forecast
-
What is the Apogee Therapeutics stock price today?
The Apogee Therapeutics stock price is 44.50 USD today. -
Will APGE stock go up or go down?
Apogee Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Apogee Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apogee Therapeutics is overvalued.
Is Apogee Therapeutics Stock a Buy?
- Apogee Therapeutics share price is 44.50 while APGE 8-day exponential moving average is 46.75, which is a Sell signal.
- The stock price of APGE is 44.50 while Apogee Therapeutics 20-day EMA is 47.87, which makes it a Sell.
- Apogee Therapeutics 50-day exponential moving average is 49.88 while APGE share price is 44.50, making it a Sell technically.
- APGE stock price is 44.50 and Apogee Therapeutics 200-day simple moving average is 45.93, creating a Sell signal.
Fundamental Analysis of Apogee Therapeutics
Is Apogee Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and a decrease next year of $0.97 per share.
Technical Analysis of Apogee Therapeutics
Should I short Apogee Therapeutics stock?
- APGE Moving Average Covergence Divergence (MACD) indicator is -1.39, suggesting Apogee Therapeutics is a Sell
- Apogee Therapeutics Relative Strength Index (RSI) is 41.05, which suggest Apogee Therapeutics is oversold
- The Bollinger Bands (25) for Apogee Therapeutics is (43.33 - 53.25), which suggest Apogee Therapeutics is a Sell
- The Bollinger Bands (100) for Apogee Therapeutics is (45.37 - 55.77), which suggest Apogee Therapeutics is a Sell
* Apogee Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.